Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA

Published:2020-05-15 Issue:7 Volume:11 Page:1861-1868
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Li Xuerui¹^ORCID,Chen Xiaoqing¹²,Wen Lingzhu¹,Wang Yulei¹,Chen Bo¹,Xue Yunlian³,Guo Liping¹²,Liao Ning¹

Affiliation:

1. Department of Breast Cancer, Cancer Center, Guangdong Provincial People's HospitalGuangdong Academy of Medical Sciences Guangzhou China

2. The Second School of Clinical MedicineSouthern Medical University Guangzhou China

3. Statistics Office, Information and Statistics Center, Guangdong Provincial People's HospitalGuangdong Academy of Medical Sciences Guangzhou China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13467

Reference33 articles.

1. Cancer statistics, 2018

2. TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance

3. Sequence analysis of mutations and translocations across breast cancer subtypes

4. Comprehensive molecular portraits of human breast tumours

5. Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public neoantigens in breast cancer immunotherapy (Review);International Journal of Molecular Medicine;2024-06-17

2. The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers;Human Genomics;2023-07-15

3. Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review;Technology in Cancer Research & Treatment;2023-01

4. Comparison of the Efficacy and Safety of Ponatinib and Dasatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia With Central Nervous System Relapse: A Retrospective Study;Technology in Cancer Research & Treatment;2023-01

5. Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer;Molecular Oncology;2022-08-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3